Published in Cancer J on July 22, 2016
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol (2013) 3.76
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol (2013) 3.70
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2002) 3.39
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol (2008) 3.02
Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol (2009) 2.78
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol (2009) 2.74
Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys (2010) 2.69
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol (2006) 2.49
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations. Acta Oncol (2009) 2.33
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol (2005) 2.20
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys (2004) 2.00
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure. Oral Oncol (2012) 1.98
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer (2011) 1.87
Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys (2012) 1.85
Assessment of a model-based deformable image registration approach for radiation therapy planning. Int J Radiat Oncol Biol Phys (2007) 1.75
Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer (2006) 1.71
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys (2012) 1.70
Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.67
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys (2012) 1.55
Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography. Int J Radiat Oncol Biol Phys (2009) 1.47
Response to letter to the editor with reference to article "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure". Oral Oncol (2013) 1.40
Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys (2003) 1.39
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol (2012) 1.38
Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg (2003) 1.28
Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin (2009) 1.28
Image-guided radiotherapy: has it influenced patient outcomes? Semin Radiat Oncol (2012) 1.23
Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.18
The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol (2011) 1.17
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer (2013) 1.16
Adapting population liver motion models for individualized online image-guided therapy. Conf Proc IEEE Eng Med Biol Soc (2008) 1.16
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol (2012) 1.12
Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.11
Radiotherapy for hepatocellular carcinoma: an overview. Ann Surg Oncol (2008) 1.10
Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat Oncol Biol Phys (2012) 1.10
Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys (2009) 1.09
Improving image-guided target localization through deformable registration. Acta Oncol (2008) 1.07
Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies. Int J Radiat Oncol Biol Phys (2008) 1.07
Cone-beam CT assessment of interfraction and intrafraction setup error of two head-and-neck cancer thermoplastic masks. Int J Radiat Oncol Biol Phys (2010) 1.06
Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy. Int J Radiat Oncol Biol Phys (2006) 1.06
Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.03
Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys (2010) 1.03
Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue. Int J Radiat Oncol Biol Phys (2006) 1.02
Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys (2010) 1.01
Alterations in normal liver doses due to organ motion. Int J Radiat Oncol Biol Phys (2003) 1.00
Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys (2006) 0.98
MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study. Radiology (2010) 0.98
Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma. Int J Radiat Oncol Biol Phys (2010) 0.97
Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration. Int J Radiat Oncol Biol Phys (2010) 0.96
Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer. Head Neck (2007) 0.94
Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma. Transpl Int (2009) 0.92
Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression. Int J Radiat Oncol Biol Phys (2010) 0.91
Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys (2002) 0.91
Three-dimensional motion of liver tumors using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys (2008) 0.90
An international survey on liver metastases radiotherapy. Acta Oncol (2012) 0.89
Protons or photons for hepatocellular carcinoma? Let's move forward together. Int J Radiat Oncol Biol Phys (2009) 0.89
Stereotactic body radiation therapy for hepatocellular carcinoma. Discov Med (2010) 0.89
Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status. Int J Radiat Oncol Biol Phys (2013) 0.89
Upper abdominal malignancies: intensity-modulated radiation therapy. Front Radiat Ther Oncol (2007) 0.88
Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib. Anticancer Drugs (2010) 0.88
Emerging role of radiotherapy in the management of liver metastases. Cancer J (2010) 0.88
Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors. Int J Radiat Oncol Biol Phys (2005) 0.87
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol (2005) 0.86
Truths and myths about radiotherapy for verrucous carcinoma of larynx. Int J Radiat Oncol Biol Phys (2008) 0.84
Malignant intracardiac thrombus from hepatocellular carcinoma treated with external beam radiation therapy. J Palliat Med (2010) 0.84
Long term control of a maxillary sinus mucoepidermoid carcinoma with low dose radiation therapy: a case report. Radiat Oncol (2013) 0.84
Neoadjuvant treatment for pancreatic cancer--a review. Crit Rev Oncol Hematol (2007) 0.84
Accumulated dose in liver stereotactic body radiotherapy: positioning, breathing, and deformation effects. Int J Radiat Oncol Biol Phys (2011) 0.83
Image-guided radiotherapy strategies in upper gastrointestinal malignancies. Front Radiat Ther Oncol (2011) 0.83
Daily targeting of intrahepatic tumors for radiotherapy. Int J Radiat Oncol Biol Phys (2002) 0.82
Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma. J Gastrointest Cancer (2012) 0.81
Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer. Head Neck (2014) 0.80
Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg (2007) 0.80
Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases. J Clin Oncol (2013) 0.80
Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum. Int J Radiat Oncol Biol Phys (2011) 0.79
Lack of influence of intravenous contrast on head and neck IMRT dose distributions. Acta Oncol (2008) 0.78
Squamous cell carcinoma arising in a proliferating pilar (trichilemmal) cyst with nodal and distant metastases. J Otolaryngol Head Neck Surg (2010) 0.78
Dosimetric analysis of radiation-induced gastric bleeding. Int J Radiat Oncol Biol Phys (2012) 0.78
Point-of-care outcome assessment in the cancer clinic: audit of data quality. Radiother Oncol (2010) 0.78
Outcome of adjuvant therapy in biliary tract cancers. Am J Clin Oncol (2015) 0.77
Image guidance and the new practice of radiotherapy: what to know and use from a decade of investigation. Front Radiat Ther Oncol (2011) 0.77
Options for radiotherapy in the treatment of liver metastases. Clin Transl Oncol (2008) 0.77
Safety considerations for IGRT: Executive summary. Pract Radiat Oncol (2013) 0.76
Adaptive management of liver cancer radiotherapy. Semin Radiat Oncol (2010) 0.76
In reply to letter to the editor by Dr Willems et al. re: Eccles et al. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations. Acta Oncol (2010) 0.76
A pragmatic contouring guideline for salivary gland structures in head and neck radiation oncology: the MOIST target. Am J Clin Oncol (2013) 0.76
Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 2006;65:189-195). Int J Radiat Oncol Biol Phys (2006) 0.75
Comparison of simple and complex liver intensity modulated radiotherapy. Radiat Oncol (2010) 0.75
Case 23-2005: a man with a mass in the liver. N Engl J Med (2005) 0.75
Bilateral extraocular muscles metastases from a choroidal melanoma. Can J Ophthalmol (2013) 0.75
Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity. Med Dosim (2009) 0.75
A randomized controlled trial of lorazepam to reduce liver motion in patients receiving upper abdominal radiation therapy. Int J Radiat Oncol Biol Phys (2013) 0.75
Image guidance in non-small cell lung cancer. Semin Radiat Oncol (2010) 0.75